Drugs / Gemeprost
Gemeprost
also known as
Cervagem · Gemeprost pessaries: Cervidil, Merck Serono SPA, Rome, Italy. · Preglandin · SC-37681 · U-37026
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy2 trials | ||||||
| Phase 2 | NCT05342467 Comparator | Nov 2022 → Oct 2024 | pregnancy disorder with abortive outcome | National University of Malaysia | Completed | No outcome recorded |
| — | NCT01860521 Comparator | Sep 2011 → Jun 2013 | — | IRCCS Azienda Ospedaliera Universitaria San Martino - IST Istituto Nazionale per la Ricerca sul Cancro, Genoa, Italy | Completed | No outcome recorded |
Evidence & citations 8 cited values
Every value below carries the sentence it was read from. 3 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Gemeprost | “Gemeprost pessaries.” NCT01860521 ↗ |
| Known as | Cervagem | ChEMBL registry synonym — accepted as the source's own label CHEMBL1908315 ↗ |
| Known as | Gemeprost pessaries: Cervidil, Merck Serono SPA, Rome, Italy. | “Gemeprost pessaries: Cervidil®, Merck Serono SPA, Rome, Italy.” NCT01860521 ↗ |
| Known as | Preglandin | ChEMBL registry synonym — accepted as the source's own label CHEMBL1908315 ↗ |
| Known as | SC-37681 | ChEMBL registry synonym — accepted as the source's own label CHEMBL1908315 ↗ |
| Known as | U-37026 | ChEMBL registry synonym — accepted as the source's own label CHEMBL1908315 ↗ |
| Modality | Small molecule | — CHEMBL1908315 ↗ |
| Route | Other | “Intravaginal gemeprost 1 mg inserted 3 hourly for maximum of 5 doses in 24 hours” NCT05342467 ↗ |